PRUCALOPRIDE SUCCINATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for prucalopride succinate and what is the scope of freedom to operate?
Prucalopride succinate
is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for PRUCALOPRIDE SUCCINATE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 2 |
Patent Applications: | 21 |
DailyMed Link: | PRUCALOPRIDE SUCCINATE at DailyMed |
Recent Clinical Trials for PRUCALOPRIDE SUCCINATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Takeda | Phase 3 |
Takeda Development Center Americas, Inc. | Phase 3 |
Shire | Phase 1 |
Pharmacology for PRUCALOPRIDE SUCCINATE
Drug Class | Serotonin-4 Receptor Agonist |
Mechanism of Action | Serotonin 4 Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PRUCALOPRIDE SUCCINATE
US Patents and Regulatory Information for PRUCALOPRIDE SUCCINATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166-002 | Dec 14, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Takeda Pharms Usa | MOTEGRITY | prucalopride succinate | TABLET;ORAL | 210166-001 | Dec 14, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.